/PRNewswire/ EmitBio Inc. is excited to announce its participation in the World Congress on Infectious Diseases, scheduled to take place from October 23 to.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
EmitBio taps Technology Public Relations Veteran James Pearson
May 5, 2021 GMT
EmitBio Inc. logo (PRNewsfoto/EmitBio Inc.)
NEW YORK and DURHAM, N.C., May 5, 2021 /PRNewswire/ EmitBio Inc., a life science company using the precise delivery of light to stimulate, heal and protect the body, today announced PR industry veteran James A. Pearson will be joining the company as Head of Global Public Relations, in a newly created position to lead global PR and strategic communications for EmitBio. EmitBio has developed the first and only in-home use prescription device designed to kill every variant of coronavirus. The company is currently seeking FDA approval through a EUA authorization for use of its light technology to combat COVID-19, with proprietary technology that can inactivate variants of the coronavirus that causes COVID-19.
POLITICO
Get the POLITICO Influence newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by REAL SOLUTIONS®, a community safety program of the firearm industry.
With Daniel Lippman
PECK MADIGAN JONES REBRANDS: Peck Madigan Jones, one of the top lobbying firms on K Street, announced today that it will drop the name and rebrand as